Gastroenterology Practice Questions

Q: Maximum dilatation of the esophagus occurs in which condition?

Achalasia cardiae. **Explanation:** **Achalasia Cardiae** is the correct answer because it is a chronic, progressive motility disorder characterized by the failure of the Lower Esophageal Sphincter (LES) to relax and the absence of peristalsis [1]. Over years, the persistent functional obstruction leads to massive proximal dilatation of the esophagus, often referred to as a **"Sigmoid Esophagus."** In advanced cases, the esophageal diameter can exceed 10 cm, representing the maximum dilatation seen in any clinical condition. **Analysis of Incorrect Options:** * **Carcinoma at the GE Junction:** While it causes significant obstruction, the progression is rapid. Patients typically present with dysphagia and weight loss within months, which does not allow enough time for the esophageal wall to undergo the massive compensatory dilatation seen in chronic achalasia. * **Stricture of the lower end:** Benign strictures (e.g., peptic strictures) cause proximal dilatation, but the fibrosis and inflammation often limit the elasticity of the esophageal wall compared to the long-standing neuromuscular failure in achalasia. * **CREST Syndrome (Scleroderma):** In Scleroderma, the esophagus becomes "aperistaltic" due to smooth muscle atrophy and fibrosis [1]. However, because the LES is typically **incompetent (low pressure)** rather than hypertensive, there is no distal obstruction to cause massive dilatation. **High-Yield NEET-PG Pearls:** * **X-ray Finding:** "Bird’s beak" or "Rat-tail" appearance on Barium swallow. * **Gold Standard Diagnosis:** Esophageal Manometry (shows incomplete LES relaxation and aperistalsis). * **Heller’s Myotomy:** The surgical treatment of choice, usually combined with a partial fundoplication to prevent reflux. * **Chagas Disease:** A secondary cause of achalasia caused by *Trypanosoma cruzi*, which destroys the myenteric (Auerbach’s) plexus.

Q: Which of the following are extrahepatic manifestations of Hepatitis?

Aplastic anemia and Cryoglobulinemia. **Explanation:** Viral hepatitis, particularly Hepatitis B (HBV) and Hepatitis C (HCV), is frequently associated with systemic immune-mediated phenomena known as extrahepatic manifestations. **Why Option A is Correct:** * **Cryoglobulinemia:** This is most strongly associated with **Hepatitis C**. Chronic HCV infection leads to B-cell proliferation and the production of mixed cryoglobulins (Type II and III). These proteins precipitate in cold temperatures, causing vasculitis, palpable purpura, and glomerulonephritis. * **Aplastic Anemia:** This is a rare but life-threatening complication known as **Hepatitis-Associated Aplastic Anemia (HAAA)**. It typically occurs 2–3 months after an episode of acute hepatitis (often non-A, non-B, non-C viruses). It is thought to be mediated by T-cell destruction of bone marrow stem cells triggered by the viral infection. **Analysis of Incorrect Options:** * **Options B, C, and D:** While Aplastic anemia and Cryoglobulinemia are classic manifestations, **Guillain-Barré Syndrome (GBS)** is a much rarer neurological association compared to the high-yield associations of cryoglobulinemia and hematological failure. In the context of NEET-PG, when forced to choose the most characteristic pair, Aplastic anemia and Cryoglobulinemia represent the most frequently tested "textbook" manifestations. **NEET-PG High-Yield Pearls:** 1. **Hepatitis B (HBV):** Most commonly associated with **Polyarteritis Nodosa (PAN)** and **Membranous Glomerulonephritis**. 2. **Hepatitis C (HCV):** Most commonly associated with **Mixed Cryoglobulinemia**, **Membranoproliferative Glomerulonephritis (MPGN)**, **Porphyria Cutanea Tarda (PCT)**, and Lichen Planus. 3. **Hepatitis E (HEV):** Specifically associated with neurological manifestations like **Neuralgic Amyotrophy** and GBS. 4. **HAAA:** Usually presents as severe pancytopenia following a bout of seronegative acute hepatitis.

Q: What is the gold standard investigation for achalasia cardia?

Esophageal manometry. **Explanation:** **Achalasia Cardia** is a primary esophageal motility disorder characterized by the failure of the Lower Esophageal Sphincter (LES) to relax and the absence of progressive peristalsis in the distal esophagus. 1. **Why Esophageal Manometry is the Gold Standard:** Manometry is the most sensitive and specific test because it directly measures the pressure and motor function of the esophagus. The diagnostic hallmarks on manometry include: * **Incomplete relaxation of the LES** (residual pressure >10 mmHg). * **Aperistalsis** in the distal two-thirds of the esophageal body. * Elevated resting LES pressure (>45 mmHg) in many cases. * *High-Yield Note:* High-resolution manometry (HRM) using the **Chicago Classification** is the current clinical standard for subtyping Achalasia (Types I, II, and III). 2. **Why other options are incorrect:** * **Barium Swallow:** Often the *initial* investigation. It shows the classic **"Bird’s beak"** appearance (tapering at the GE junction) and proximal dilatation, but it cannot definitively diagnose motility patterns. * **Endoscopy (OGD):** Primarily used to **rule out malignancy** (Pseudoachalasia) at the GE junction. While it may show retained food or resistance at the cardia ("pop" sensation), it is not diagnostic for motility. * **Endoscopic Ultrasound (EUS):** Useful for evaluating mural thickening or extrinsic compression in suspected malignancy but has no role in the primary diagnosis of Achalasia. **Clinical Pearls for NEET-PG:** * **Most common symptom:** Dysphagia to both solids and liquids (paradoxical dysphagia). * **Heller’s Myotomy:** The surgical treatment of choice (usually combined with a partial fundoplication like Dor or Toupet). * **POEM (Per-Oral Endoscopic Myotomy):** A newer, minimally invasive endoscopic treatment. * **Chagas Disease:** A common cause of secondary achalasia (caused by *Trypanosoma cruzi*).

Q: A 60-year-old man presents with choreoathetosis and Kayser-Fleischer rings in the cornea. What is the initial treatment of choice?

Zinc. The patient presents with classic features of **Wilson’s Disease** (Hepatolenticular degeneration), characterized by neurological symptoms (choreoathetosis) and pathognomonic **Kayser-Fleischer (KF) rings** [1]. **Why Zinc is the Correct Answer:** In the context of NEET-PG and current clinical guidelines, **Zinc** is considered the treatment of choice for the **initial management of neurological Wilson’s Disease**. Chelators like Penicillamine can cause a "paradoxical worsening" of neurological symptoms in up to 50% of patients due to the rapid mobilization of copper from the liver into the brain. Zinc works by inducing **metallothionein** in intestinal mucosal cells, which sequesters dietary copper and prevents its absorption, offering a safer profile for patients with neurological involvement. **Analysis of Incorrect Options:** * **B. Penicillamine:** While it is a potent chelator, it is no longer the first-line for neurological cases due to the high risk of permanent neurological deterioration. It remains a primary option for symptomatic hepatic Wilson’s. * **C. Pyridoxine:** This is Vitamin B6. It is often co-administered with Penicillamine to prevent drug-induced deficiency, but it has no therapeutic effect on copper metabolism. * **D. Trientine:** This is a chelating agent used primarily in patients who are intolerant to Penicillamine. Like Penicillamine, it carries a risk of neurological worsening, though slightly lower. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** Best initial test is **Serum Ceruloplasmin** (decreased); Gold standard is **Liver biopsy** (increased copper). * **KF Rings:** Located in the **Descemet’s membrane** of the cornea; seen best on Slit-lamp exam. * **MRI Brain:** Classic **"Face of the Giant Panda"** sign in the midbrain. * **Maintenance:** Zinc is the drug of choice for maintenance therapy and asymptomatic patients.

Q: A diagnosis of chronic hepatitis is made if liver disease is present for a minimum of:

6 months. **Explanation:** The diagnosis of **chronic hepatitis** is defined by the presence of clinical, biochemical, or serological evidence of liver inflammation and necrosis for a **minimum of 6 months** [1]. This timeframe is the standard clinical threshold used to differentiate acute liver injury from chronic disease. * **Why 6 months is correct:** In most cases of acute viral hepatitis (such as Hepatitis B), the body’s immune system typically clears the virus or resolves the inflammation within 3 to 6 months. Persistence beyond the 6-month mark indicates that the immune system has failed to clear the insult, leading to potential progressive fibrosis and cirrhosis [1]. **Analysis of Incorrect Options:** * **3 weeks & 6 weeks (Options A & B):** These durations fall strictly within the **acute phase** of hepatitis [1]. Most acute infections show peak transaminase levels and symptomatic presentation within this window. * **3 months (Option D):** While some guidelines for specific conditions (like certain drug-induced liver injuries) monitor progress at 3 months, the universal definition for "chronic" hepatitis across major textbooks (Harrison’s, Davidson’s) remains 6 months. **High-Yield Clinical Pearls for NEET-PG:** * **Hepatitis B:** Persistence of **HBsAg for >6 months** is the hallmark of chronic HBV infection [1]. * **Hepatitis C:** Unlike HBV, HCV has a high chronicity rate; approximately **80%** of acute infections progress to chronic hepatitis. * **Hepatitis E:** Generally causes acute hepatitis, but can become **chronic in immunocompromised patients** (e.g., organ transplant recipients). * **Hepatitis A & D:** Hepatitis A **never** causes chronic disease. Hepatitis D only becomes chronic if it occurs as a co-infection or super-infection with Hepatitis B.

Question 1

A jaundiced, 43-year-old alcoholic male presents with bright red blood in his last two stools. He denies pain on defecation or changes in his bowel habits. Which of the following would be the most likely finding on sigmoidoscopic examination?

Accepted Answer

Hemorrhoids

Answer

Colorectal carcinoma

Answer

Diverticulitis

Answer

Hyperplastic polyps

Question 2

Maximum dilatation of the esophagus occurs in which condition?

Accepted Answer

Achalasia cardiae

Answer

Carcinoma at the gastroesophageal junction

Answer

Stricture of the lower end

Answer

CRUST syndrome

Question 3

Consider the following statements with reference to duodenal ulcers:

Accepted Answer

Infection with H. pylori and NSAID-induced injury account for the majority of duodenal ulcers.

Answer

They occur most often in the second part of the duodenum.

Answer

Malignant duodenal ulcers are extremely rare.

Answer

Eradication of H. pylori has greatly reduced the recurrence rates in duodenal ulcers.

Question 4

Which of the following are extrahepatic manifestations of Hepatitis?

Accepted Answer

Aplastic anemia and Cryoglobulinemia

Answer

Aplastic anemia

Answer

Aplastic anemia and Guillain-Barré syndrome

Answer

Cryoglobulinemia and Guillain-Barré syndrome

Question 5

What is the gold standard investigation for achalasia cardia?

Accepted Answer

Esophageal manometry

Answer

Barium swallow

Answer

Endoscopy

Answer

Endoscopic ultrasound

Question 6

A 60-year-old man presents with choreoathetosis and Kayser-Fleischer rings in the cornea. What is the initial treatment of choice?

Accepted Answer

Zinc

Answer

Penicillamine

Answer

Pyridoxine

Answer

Trientine

Question 7

A 26-year-old woman in the first trimester of pregnancy presents with retching and repeated vomiting accompanied by large hematemesis. Her pulse rate is 126/minute and blood pressure is 80 mm Hg systolic. What is the most likely diagnosis?

Accepted Answer

Mallory-Weiss syndrome

Answer

Bleeding from esophageal varices

Answer

Peptic ulcer

Answer

Hiatus hernia

Question 8

Toxic megacolon is a known complication of which of the following conditions?

Accepted Answer

Ulcerative colitis

Answer

Pseudomembranous colitis

Answer

Amebic colitis

Answer

Hirschsprung's disease

Question 9

A diagnosis of chronic hepatitis is made if liver disease is present for a minimum of:

Accepted Answer

6 months

Answer

3 weeks

Answer

6 weeks

Answer

3 months

Question 10

A patient presented to the emergency ward with a massive upper gastrointestinal bleed. On examination, the patient has mild splenomegaly. In the absence of any other information available, which of the following is the most appropriate therapeutic modality?

Accepted Answer

Intravenous pantoprazole

Answer

Intravenous propranolol

Answer

Intravenous vasopressin

Answer

Intravenous somatostatin

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?